Ikarian Capital, LLC Deciphera Pharmaceuticals, Inc. Put Options Transaction History

Ikarian Capital, LLC

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 13, 2022	SELL	$6.87 - $11.11 $5,496 - $8,888	-800 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$7.7 - $37.13 $763,840 - $3.68 Million	-99,200 Reduced 99.2%	800 $8,000
Q2 2020 Aug 14, 2020	BUY	$37.05 - $65.03 $3.7 Million - $6.5 Million	100,000 New	100,000 $5.97 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.